520 related articles for article (PubMed ID: 17484159)
1. [Therapeutic perspectives of linezolid in the management of infections due to multiresistant Gram-positive pathogens].
Manfredi R
Recenti Prog Med; 2007 Mar; 98(3):143-54. PubMed ID: 17484159
[TBL] [Abstract][Full Text] [Related]
2. Update on the appropriate use of linezolid in clinical practice.
Manfredi R
Ther Clin Risk Manag; 2006 Dec; 2(4):455-64. PubMed ID: 18360656
[TBL] [Abstract][Full Text] [Related]
3. Treatment options for vancomycin-resistant enterococcal infections.
Linden PK
Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009.
Dowzicky MJ
Clin Ther; 2011 Dec; 33(12):1964-73. PubMed ID: 22078154
[TBL] [Abstract][Full Text] [Related]
5. Antibiotics for gram-positive bacterial infections. Vancomycin, teicoplanin, quinupristin/dalfopristin, and linezolid.
Lundstrom TS; Sobel JD
Infect Dis Clin North Am; 2000 Jun; 14(2):463-74. PubMed ID: 10829266
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of treatments used in infections caused by gram-positive multiresistant cocci in critically ill patients admitted to the ICU].
Álvarez-Lerma F; Palomar Martínez M; Olaechea Astigarraga P; Insausti Ordeñana J; López Pueyo MJ; Gracia Arnillas MP; Gimeno Costa R; Seijas Betolaza I
Rev Esp Quimioter; 2012 Mar; 25(1):65-73. PubMed ID: 22488544
[TBL] [Abstract][Full Text] [Related]
7. New antibiotics for the treatment of severe staphylococcal infection in the critically ill patient.
Schmidt-Ioanas M; de Roux A; Lode H
Curr Opin Crit Care; 2005 Oct; 11(5):481-6. PubMed ID: 16175036
[TBL] [Abstract][Full Text] [Related]
8. [Linezolide in paediatrics].
Moulin F; Ménager C
Arch Pediatr; 2010 Sep; 17 Suppl 4():S133-9. PubMed ID: 20826321
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of linezolid & quinupristin/dalfopristin against Gram-positive cocci.
Tünger A; Aydemir S; Uluer S; Cilli F
Indian J Med Res; 2004 Dec; 120(6):546-52. PubMed ID: 15654141
[TBL] [Abstract][Full Text] [Related]
10. [Update of antimicrobial resistance in Gram-positive microorganisms].
Cercenado E
Med Clin (Barc); 2010 Dec; 135 Suppl 3():10-5. PubMed ID: 21477699
[TBL] [Abstract][Full Text] [Related]
11. Linezolid--a new option for treating gram-positive infections.
Batts DH
Oncology (Williston Park); 2000 Aug; 14(8 Suppl 6):23-9. PubMed ID: 10989821
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro activities of daptomycin, linezolid, and quinupristin/dalfopristin against Gram-positive bacterial isolates from a large cancer center.
Smith PF; Booker BM; Ogundele AB; Kelchin P
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):255-9. PubMed ID: 15935606
[TBL] [Abstract][Full Text] [Related]
13. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
Huang YT; Liao CH; Teng LJ; Hsueh PR
Clin Microbiol Infect; 2008 Feb; 14(2):124-9. PubMed ID: 18076671
[TBL] [Abstract][Full Text] [Related]
14. Linezolid for the treatment of resistant gram-positive cocci.
Bain KT; Wittbrodt ET
Ann Pharmacother; 2001 May; 35(5):566-75. PubMed ID: 11346064
[TBL] [Abstract][Full Text] [Related]
15. A re-emerging class of antimicrobial agents: streptogramins (quinupristin/dalfopristin) in the management of multiresistant gram-positive nosocomial cocci in hospital setting.
Manfredi R
Mini Rev Med Chem; 2005 Dec; 5(12):1075-81. PubMed ID: 16375753
[TBL] [Abstract][Full Text] [Related]
16. [Staphylococcus aureus and antibiotic resistance].
Sancak B
Mikrobiyol Bul; 2011 Jul; 45(3):565-76. PubMed ID: 21935792
[TBL] [Abstract][Full Text] [Related]
17. [Role of linezolid in antimicrobial therapy].
Carmona PM; Romá E; Monte E; García J; Gobernado M
Enferm Infecc Microbiol Clin; 2003 Jan; 21(1):30-41. PubMed ID: 12550042
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial resistance among gram-positive organisms in the intensive care unit.
Clark NM; Hershberger E; Zervosc MJ; Lynch JP
Curr Opin Crit Care; 2003 Oct; 9(5):403-12. PubMed ID: 14508154
[TBL] [Abstract][Full Text] [Related]
19. [Linezolid, an agent from a new class of antibiotics].
Kuijper EJ; Schippers EF; Bernards AT
Ned Tijdschr Geneeskd; 2004 Aug; 148(32):1577-81. PubMed ID: 15382556
[TBL] [Abstract][Full Text] [Related]
20. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections.
Chien JW; Kucia ML; Salata RA
Clin Infect Dis; 2000 Jan; 30(1):146-51. PubMed ID: 10619743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]